Skip to content
10-K

Annual Report

CITIUS ONCOLOGY, INC. CTOR

0001213900-25-125331

← back to feed
Filed
Dec 23, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 23, 2025 84.8M sh
Shares Diluted FY 2025 · Sep 30, 2025 73.27M sh
Shares Diluted FY 2025 · Sep 30, 2024 68.05M sh
Operating Cash Flow FY 2025 · Sep 30, 2025 −$5.49M
Operating Cash Flow FY 2025 · Sep 30, 2024 $126.35K
Stockholders Equity FY 2025 · Sep 30, 2025 $44.87M
Stockholders Equity FY 2025 · Sep 30, 2024 $46.14M
Stockholders Equity FY 2025 · Sep 30, 2023 $25.54M
Current Liabilities FY 2025 · Sep 30, 2025 $49.49M
Current Liabilities FY 2025 · Sep 30, 2024 $32.7M
Total Liabilities FY 2025 · Sep 30, 2025 $56.08M
Total Liabilities FY 2025 · Sep 30, 2024 $38.23M
Current Assets FY 2025 · Sep 30, 2025 $27.54M
Current Assets FY 2025 · Sep 30, 2024 $10.97M
Total Assets FY 2025 · Sep 30, 2025 $100.94M
Total Assets FY 2025 · Sep 30, 2024 $84.37M
Eps Diluted FY 2025 · Sep 30, 2025 −$0.34
Eps Diluted FY 2025 · Sep 30, 2024 −$0.31
Eps Basic FY 2025 · Sep 30, 2025 −$0.34
Eps Basic FY 2025 · Sep 30, 2024 −$0.31
Sga Expense FY 2025 · Sep 30, 2025 $8.78M
Sga Expense FY 2025 · Sep 30, 2024 $8.15M
Rd Expense FY 2025 · Sep 30, 2025 $6.42M
Rd Expense FY 2025 · Sep 30, 2024 $4.93M
Net Income FY 2025 · Sep 30, 2025 −$24.76M
Net Income FY 2025 · Sep 30, 2024 −$21.15M
Operating Income FY 2025 · Sep 30, 2025 −$23.52M
Operating Income FY 2025 · Sep 30, 2024 −$20.57M